Open AccessRecurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation
Author(s) -
Praveerayanan,
Kristin C. Mara,
Manhal Izzy,
Ross A. Dierkhising,
Julie K. Heimbach,
Alina M. Allen,
Kymberly D. Watt
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002317
Subject(s) - medicine , steatosis , hazard ratio , liver transplantation , gastroenterology , proportional hazards model , diabetes mellitus , steatohepatitis , nonalcoholic fatty liver disease , population , fatty liver , confidence interval , transplantation , disease , endocrinology , environmental health
Hepatic steatosis is strongly associated with cardiovascular disease in the general population. Whether recurrent or de novo, it can occur in the allograft, but the impact on survival and long-term clinical outcomes remains unclear. In this study, we aim to determine both the frequency and impact of allograft steatosis on long-term posttransplant outcomes.